Kimberly Manhard, Executive VP, Drug Development at HERON THERAPEUTICS, INC. /DE/ (HRTX), sold 6,000 shares at $32.07 ($192K) on 2018-10-01, disclosed to the SEC on 2018-10-02.
Open-market sale of $192k HRTX by Executive VP, Drug Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| INBX | BUY | 2024-08-30 | $140K | — | Filing → |
| HRTX | SELL | 2022-05-04 | $7K | — | Filing → |
| HRTX | SELL | 2021-05-04 | $27K | — | Filing → |